NWBO is not running trials to gain approval to treat multi-solid cancer tumors nor will it ever thus it will never gain approval for multi-solid tumors.
NWBOs value when bought will be based on the approval to treat n and r GBM cancer indication nothing more nothing less. Its not that difficult really.
There are many biotechs out there that claim to have a potential treatment for all solid tumors.